Last quarter (Q3 2024), Monopar Therapeutics Inc's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Monopar Therapeutics Inc's net income was $-1.30M. See Monopar Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Operating Expense	$ 3.71M	$ 8.83M	$ 10.54M	$ 9.13M	$ 6.51M	$ 4.32M
Operating Income	$ -7.15M	$ -8.83M	$ -10.54M	$ -9.13M	$ -6.51M	$ -4.32M
Net Non Operating Interest Income Expense	$ 367.24K	$ 429.04K	$ 21.24K	$ 24.02K	$ 81.90K	$ 98.89K
Other Income Expense	$ -171.28K	$ ―	$ -15.04K	$ ―	$ -122.40K	$ ―
Pretax Income	$ -3.17M	$ -8.40M	$ -10.50M	$ -9.10M	$ -6.30M	$ -4.22M
Tax Provision	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -6.61M	$ -8.40M	$ -10.50M	$ -9.10M	$ -6.30M	$ -4.22M
Basic EPS	$ -0.71	$ -0.61	$ ―	$ -0.73	$ -0.58	$ ―
Diluted EPS	$ -0.71	$ -0.61	$ ―	$ -0.73	$ -0.58	$ -0.45
Basic Average Shares	$ 51.13M	$ 13.82M	$ 12.72M	$ 12.47M	$ 10.96M	$ 9.32M
Diluted Average Shares	$ 51.13M	$ 13.82M	$ 12.72M	$ 12.47M	$ 10.96M	$ 9.32M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 3.71M	$ 8.83M	$ 10.54M	$ 9.13M	$ 6.51M	$ 4.32M
Net Income From Continuing And Discontinued Operation	$ -6.61M	$ -8.40M	$ -10.52M	$ -9.10M	$ -6.30M	$ -4.22M
Normalized Income	$ -4.53M	$ ―	$ -8.30M	$ -7.19M	$ ―	$ ―
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -3.44M	$ -8.83M	$ -10.52M	$ -9.13M	$ -6.51M	$ -4.32M
EBITDA	$ -3.44M	$ -8.83M	$ -10.52M	$ -9.13M	$ -6.51M	$ -4.32M

Currency in USD

Monopar Therapeutics Inc Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing